Customer Stories / Life Sciences

Pfizer logo

AWS re:Invent 2023

Pfizer at AWS re:Invent 2023

In this AWS re:Invent 2023 video, Lidia Fonseca, chief digital and technology officer at Pfizer, discusses how the company uses artificial intelligence (AI) and Amazon Web Services (AWS) to achieve the scale to treat more than 1.3 billion people with medicines and vaccines in 2022. Fonseca shows how Pfizer centralized its data, cultivated strong AI talent, and built a secure global foundation in the cloud while saving tens of millions of dollars annually. Pfizer and AWS created the Scientific Data Cloud, which aggregates data from hundreds of laboratory instruments to make it simpler and faster for scientists to search the data. On AWS, Pfizer built VOX, a generative AI solution that uses large language models from Amazon SageMaker and Amazon Bedrock, to accelerate research, predict product yield, and help it deliver more medicines to patients. 

Pfizer’s close relationship with AWS also helped it respond quickly to the COVID-19 pandemic. In the first weeks, AWS provided additional compute capacity on demand to accelerate manufacturing and clinical trials. Learn how Pfizer migrated tens of thousands of applications, databases, and servers in just a few months to transform from a company with just 10 percent of its infrastructure in the cloud into one that’s 80 percent cloud based.

kr_quotemark

Data and AI are critical to our ambitious goal to launch 19 medicines and vaccines in just 18 months. Our success rests on the groundwork we laid for technology and AI to flourish. We centralized our data, created standard platforms, and built a secure foundation, all to innovate for maximum impact. We couldn’t have achieved this tremendous reach without our close relationship with AWS”

Lidia Fonseca
Chief Digital and Technology Officer, Pfizer

About Pfizer

Pfizer Inc. is one of the world's largest pharmaceutical companies. In 2019, the incoming CEO and CTO determined that Pfizer would become a digital leader. Its investment in cloud played a key role in enabling Pfizer to move at the speed required in Pfizer's response to the COVID-19 pandemic. Pfizer aims to migrate its 10 thousand servers to AWS in less than 1 year.

Customer Speaker: Lidia Fonseca

Lidia Fonseca, Pfizer

Lidia Fonseca is the Chief Digital and Technology Officer at Pfizer, responsible for enterprise-wide digital, data and technology strategy and solutions to support the purpose of delivering Breakthroughs that Change Patients’ Lives. She also leads Learning and Development and Business Process Excellence. In her prior role, Lidia was CIO at Quest Diagnostics, the world’s leading provider of diagnostic information services. She earned a BA from the University of California, Berkeley and an MBA and Master Business Informatics from Rotterdam School of Management, Erasmus Graduate School of Business.

More Life Sciences Customer Stories

Showing results: 25-28
Total results: 216

no items found 

  • Other

    Delivering innovative health with generative AI solutions at Merck

    In this video, learn how Merck leverages AWS services to solve a common problem in the pharmaceutical industry: The occurrence of false rejects.
    2024
  • United States

    Netsmart Reduces the Burden of Clinical Documentation with Generative AI Services on AWS

    Netsmart extended their solutions capabilities by leveraging AWS HealthScribe, a HIPAA-eligible service that automatically create clinical notes from patient-clinician conversations using generative AI. Netsmart is also leveraging Amazon Bedrock to customize industry leading foundational models with enterprise-grade security and privacy built in.
    2024
  • United Arab Emirates

    Technology Innovation Institute trains the state-of-the-art Falcon LLM 40B foundation model on Amazon SageMaker

    United Arab Emirate’s (UAE) Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council, has launched Falcon LLM, a foundational large language model (LLM) with 40 billion parameters. TII is a leading global research center dedicated to pushing the frontiers of knowledge.
    2023
  • Other

    Key takeaways from Gilead’s Innovation Talk at re:Invent 2023

    At re:Invent 2023, Marc Berson, Chief Information Officer of Gilead Sciences, joined an Innovation Talk on ‘Generative AI for Industries’, along with Shaown Nandi, AWS Director of Technology for Industries. The talk highlighted Gilead’s approach towards using generative AI for accelerating therapeutic breakthroughs, and emphasized their commitment to establishing a resilient cloud infrastructure and solid data foundations, to enable the technology at an enterprise level.
    2024
1 54